Galectin Therapeutics shares owned by Benchmark Capital Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Benchmark Capital Advisors
from 13F filings
Historical chart of Benchmark Capital Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Benchmark Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Benchmark Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2018-12-31 | $764k | 223k | 3.43 |
| 2018-09-30 | $1.3M | 223k | 6.01 |
| 2018-06-30 | $1.4M | 222k | 6.36 |
| 2018-03-31 | $1.1M | 222k | 4.74 |
| 2017-12-31 | $619k | 185k | 3.34 |
| 2017-09-30 | $416k | 194k | 2.14 |
| 2017-06-30 | $478k | 194k | 2.46 |
| 2017-03-31 | $447k | 194k | 2.30 |
| 2016-12-31 | $194k | 198k | 0.98 |
| 2016-09-30 | $134k | 118k | 1.13 |
| 2016-06-30 | $88k | 60k | 1.48 |
| 2016-03-31 | $85k | 60k | 1.43 |
| 2015-12-31 | $98k | 60k | 1.64 |
| 2015-09-30 | $163k | 70k | 2.34 |
| 2015-06-30 | $195k | 72k | 2.72 |
| 2015-03-31 | $334k | 100k | 3.35 |
| 2014-12-31 | $347k | 100k | 3.47 |
| 2014-09-30 | $672k | 134k | 5.03 |
| 2014-06-30 | $1.2M | 89k | 13.81 |
| 2014-03-31 | $1.3M | 85k | 15.31 |
| 2013-12-31 | $687k | 85k | 8.08 |
| 2013-09-30 | $653k | 66k | 9.97 |
| 2013-06-30 | $85k | 20k | 4.25 |
| 2013-03-31 | $72k | 20k | 3.60 |
More positions owned by Benchmark Capital Advisors
View all positions for Benchmark Capital Advisors